Cyclic Tetrapeptides Bearing a Sulfhydryl Group Potently Inhibit Histone Deacetylases
- 1 December 2003
- journal article
- letter
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 5 (26) , 5079-5082
Abstract
New inhibitors of histone deacetylase (HDAC) containing a sulfhydryl group were designed on the basis of the corresponding hydroxamic acid (CHAP31) and FK228. Their disulfide dimers and hybrids exhibited potent HDAC inhibitory activity in vivo with potential as anticancer prodrugs.Keywords
This publication has 13 references indexed in Scilit:
- Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme and Cellular Activity of Straight Chain HydroxamatesJournal of Medicinal Chemistry, 2002
- Deacetylase EnzymesChemistry & Biology, 2002
- Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxinProceedings of the National Academy of Sciences, 2000
- Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitorsNature, 1999
- Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide DerivativesJournal of Medicinal Chemistry, 1999
- A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumorsProceedings of the National Academy of Sciences, 1999
- Analogs of the cytostatic and antimitogenic agents chlamydocin and HC-toxin: synthesis and biological activity of chloromethyl ketone and diazomethyl ketone-functionalized cyclic tetrapeptidesJournal of Medicinal Chemistry, 1987
- Studies on WF-3161, a new antitumor antibiotic.The Journal of Antibiotics, 1983
- Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatographyBiochemistry, 1979
- Isolierung und Strukturaufklärung von ChlamydocinHelvetica Chimica Acta, 1974